Found: 2
Select item for more details and to access through your institution.
Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 1993, doi. 10.3390/vaccines10121993
- By:
- Publication type:
- Article
KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1404051
- By:
- Publication type:
- Article